Patents by Inventor Matthew Pellan CHENG

Matthew Pellan CHENG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230323455
    Abstract: The present disclosure is directed to methods for assessing the severity and progression of a SARS-CoV2 infection in a subject using cell-free DNA (cfDNA). The present disclosure is further directed to methods for assessing tissue damage as a result of SARS-CoV2 infection. In addition, the present disclosure provides methods for treating a SARS-CoV2 infection in a subject. Finally, the disclosure also provides methods for detecting a microbial co-infection of a subject suffering from a SARS-CoV2 infection.
    Type: Application
    Filed: July 23, 2021
    Publication date: October 12, 2023
    Inventors: Iwijn DE VLAMINCK, Alexandre Pellan CHENG, Matthew Pellan CHENG, Donald Cuong VINH, Wei GU, Charles CHIU
  • Publication number: 20230257822
    Abstract: The present disclosure is directed to novel methods for detecting tissue damage, graft-versus-host disease (GVHD), microbial infections, presence of a tumor, and loss of engraftment in a subject using cell-free DNA (cfDNA) profiling. The methods of the disclosure are in part based on the recognition that damaged tissues, microbes during an infection, tumors, and donor cells (e.g., in a hematopoietic cell transplantation) shed small fragments of cfDNA into blood circulation.
    Type: Application
    Filed: April 23, 2021
    Publication date: August 17, 2023
    Inventors: Iwijn DE VLAMINCK, Alexandre Pellan CHENG, Matthew Pellan CHENG, Francisco Miguel MARTY, Jerome RITZ